Home › Funds › CenterBook Partners LP › GENI
CenterBook Partners LP position in GENI
GENIUS SPORTS LIMITED · Consumer Discretionary
CenterBook Partners LP reported holding 1,476,166 shares of GENI (GENIUS SPORTS LIMITED) in its Q2 2026 13F filing — a position valued at US$8.9M, representing 0.44% of its reported portfolio and ranking #50 among its reported holdings. CenterBook Partners LP has disclosed GENI holdings in 6 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How CenterBook Partners LP's GENI position evolved
CenterBook Partners LP first disclosed a stake in GENI in Q3 2023 at 488,590 shares (US$2.6M). The position peaked in Q2 2026 at 1,476,166 shares, worth US$8.9M. Across 6 filings, CenterBook Partners LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,476,166 shares valued at US$8.9M — an increase of 1,376,737 shares quarter over quarter.. Notable position changes include a 83% trim in Q1 2024 (shares fell 5% over the following quarter), a 54% trim in Q1 2026 (shares rose 37% over the following quarter), a 1385% increase in Q2 2026 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 488.59K | $2.60M | New |
| Q4 2023 | 538.02K | $3.32M | Add |
| Q1 2024 | 91.69K | $523.53K | Reduce |
| Q4 2025 | 218.44K | $2.41M | New |
| Q1 2026 | 99.43K | $440.47K | Reduce |
| Q2 2026 | 1.48M | $8.95M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GENI and 13F data
GENI (GENIUS SPORTS LIMITED) is a Consumer Discretionary company. 25 other funds we track also report a position in GENI — the largest reported positions include Senvest Management, LLC (US$96.2M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$81.8M), SHAPIRO CAPITAL MANAGEMENT LLC (US$59.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GENI
- Senvest Management, LLC 15.88M sh · $96.24M · Q2 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 13.50M sh · $81.78M · Q2 2026
- SHAPIRO CAPITAL MANAGEMENT LLC 9.89M sh · $59.92M · Q2 2026
- DISCOVERY CAPITAL MANAGEMENT, LLC / CT 7.23M sh · $43.82M · Q2 2026
- Portolan Capital Management, LLC 7.03M sh · $42.58M · Q2 2026
- Granahan Investment Management, LLC 7.02M sh · $42.57M · Q2 2026
- Voss Capital, LP 6.85M sh · $41.51M · Q2 2026
- NEEDHAM INVESTMENT MANAGEMENT LLC 4.92M sh · $29.85M · Q2 2026
- Samjo Management, LLC 4.91M sh · $29.77M · Q2 2026
- Global Alpha Capital Management Ltd. 4.44M sh · $28.17M · Q2 2026
- CYPRESS POINT INVESTMENT MANAGEMENT LP 4.15M sh · $25.16M · Q2 2026
- IFC Advisors LLC 4.05M sh · $24.56M · Q2 2026
More on CenterBook Partners LP
FAQ
How long has CenterBook Partners LP held GENI?
CenterBook Partners LP has disclosed GENI holdings in 6 of the last 12 reported quarters, going back to Q3 2023.
What is CenterBook Partners LP's current position in GENI?
As of Q2 2026, CenterBook Partners LP holds 1.48M shares of GENI (GENIUS SPORTS LIMITED), valued at $8.95M, representing 0.44% of its reported portfolio and ranking #50.
Has CenterBook Partners LP been buying or selling GENI?
In the latest 13F filing (Q2 2026), CenterBook Partners LP increased its position in GENI. The position peaked in Q2 2026 at 1.48M shares.
Which other funds hold GENI?
Other major institutional holders of GENI include Senvest Management, LLC, GLENVIEW CAPITAL MANAGEMENT, LLC, SHAPIRO CAPITAL MANAGEMENT LLC, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.